Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
International Journal of Antimicrobial Agents|March 15, 2022
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniaeRajnikant Sharma, Estefany Garcia, John K Diep, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2023
Proof-of-concept for incorporating mechanistic insights from multi-omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniaePatrick O Hanafin, Nusaibah Abdul Rahim, Rajnikant Sharma, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaNeang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 22, 2023
International society of Pharmacometrics Mentorship Program (IMP): feedback survey from the first cohort of mentor-mentee pairsPatrick O Hanafin, Ananya Murthy, Dhananjay Marathe, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
Jac-Antimicrobial Resistance|May 9, 2022
Clinical challenges treating <i>Stenotrophomonas maltophilia</i> infections: an updateMaria F Mojica, Romney Humphries, John J Lipuma, et al.
International Journal of Antimicrobial Agents|February 22, 2026
A window into resistance: the MEGA-plate as a model of evolutionary dynamicsMaytham Hussein, Rafah Allobawi, James Barclay, et al.
Frontiers in Pharmacology|August 19, 2021
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic FibrosisPatrick O Hanafin, Isabelle Sermet-Gaudelus, Matthias Griese, et al.
Pageof 8